CLN8 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-91333
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Synthetic peptide directed towards the N terminal of human CLN8. Peptide sequence MNPASDGGTSESIFDLDYASWGIRSTLMVAGFVFYLGVFVVCHQLSSSLN. The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.
Scientific Data Images for CLN8 Antibody
![Western Blot: CLN8 Antibody [NBP1-91333]](https://resources.bio-techne.com/images/products/CLN8-Antibody-Western-Blot-NBP1-91333-img0003.jpg "Western Blot: CLN8 Antibody [NBP1-91333]")
Western Blot: CLN8 Antibody [NBP1-91333]
Western Blot: CLN8 Antibody [NBP1-91333] - Titration: 0.2-1 ug/ml, Positive Control: Hela cell lysate.Applications for CLN8 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: CLN8
Alternate Names
C8orf61, ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation), EPMR
Gene Symbol
CLN8
UniProt
Additional CLN8 Products
Product Documents for CLN8 Antibody
Product Specific Notices for CLN8 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...